J. Bednarski, Elwira Bakuła-Ostalska, I. Gorczyca, O. Jelonek, B. Wożakowska-Kapłon, B. Uziębło-Życzkowska, M. Maciorowska, M. Wójcik, R. Błaszczyk, R. Rajtar-Salwa, T. Tokarek, J. Bil, Michał Wojewódzki, Anna Szpotowicz, M. Krzciuk, M. Gawałko, A. Kapłon-Cieślicka, A. Tomaszuk-Kazberuk, A. Szyszkowska, M. Wełnicki, A. Mamcarz
{"title":"Clinical characteristics of patients based on the POL-AF registry compared to the registries of the pre - NOACs era. Do we still treat the same individuals?","authors":"J. Bednarski, Elwira Bakuła-Ostalska, I. Gorczyca, O. Jelonek, B. Wożakowska-Kapłon, B. Uziębło-Życzkowska, M. Maciorowska, M. Wójcik, R. Błaszczyk, R. Rajtar-Salwa, T. Tokarek, J. Bil, Michał Wojewódzki, Anna Szpotowicz, M. Krzciuk, M. Gawałko, A. Kapłon-Cieślicka, A. Tomaszuk-Kazberuk, A. Szyszkowska, M. Wełnicki, A. Mamcarz","doi":"10.15761/vdt.1000189","DOIUrl":"https://doi.org/10.15761/vdt.1000189","url":null,"abstract":"","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116999081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Nikas, Konstantinos Tigkiropoulos, I. Lazaridis, Nikoletta Kolaki, M. Tympanidou, Kyriakos Stavridis, D. Karamanos, N. Saratzis
Purpose: To present the succesfull endovascular repair of impending rupture of thoracic saccular aneurysm in patient with MAGIC syndrome. Case: A 51-year-old man with a history of MAGIC syndrome was transferred to our vascular unit with a 3 days history of thoracic pain and hemoptysis. Contrast enhanced computed tomography depicted a contained rupture of a saccular aneurysm in the distal part of descending thoracic aorta. The patient was successfully managed with thoracic endovascular aortic repair (TEVAR) and Anti-TNFa factor. His immediate postoperative course was uneventful. Follow up at 2 months depicted thrombosed saccular aneurysm with excellent patency and absence of migration and endoleak. Conclusion: Mid-term outcome of endovascular repair in patients with MAGIC syndrome seems to be safe. Due to the nature of the disease and its rarity, more studies are necessary to establish its efficacy. *Correspondence to: Tigkiropoulos K, Vascular Unit,1st Department of Surgery, Aristotle University Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece, Tel: 00306944173723; E-mail: kostastig@yahoo.com Received: July 23, 2019; Accepted: July 30, 2019; Published: August 02, 2019 Introduction MAGIC (Mouth And Genital ulcers with Inflamed Cartilage) syndrome is a very rare entity, which includes clinical manifestations of Behçet’s disease (BD) and Relapsing Polychondritis (RP) [1]. Aneurysms are considered a common complication in patients with MAGIC syndrome (21.1%), even under immunosuppression therapy, requiring emergency surgery due to its clinical presentation. Vascular involvement occurs in 14.7%-27.7% of Behcet’s Disease patients [2-4]. Aortic aneurysm is well described pathology even in this subpopulation, and its optimal treatment with immunosuppressant therapy and surgical treatment, remains to be defined. In Relapsing Polychondritis patients, aneurysms or aortitis develop in 5-10% of the patients and are multiple in 50% of them, usually involving the ascending aorta [2]. They are characterized by their presence even during remission of the disease and under lifelong immunosuppression therapy [3]. Aortic involvement is generally asymptomatic, most patients present with sudden rupture of the arterial wall with devastating and poor outcome. These aneurysms typically have a faster growing rate and rupture more easily, due to the inflammatory nature of the underlying disease. The recommended treatment for aneurysmatic disease in patients with Behçet’s Disease and Relapsing Polychondritis is based on series of isolated cases reports with small number of patients, including lifelong immunosuppressant therapy and surgical intervention, either open or endovascular. We report the successful endovascular repair of a ruptured saccular aneurysm in descending thoracic aorta followed by Anti-TNFa therapy in a patient with MAGIC syndrome.
{"title":"Endovascular repair of a ruptured thoracic saccular aneurysm in a patient with MAGIC Syndrome: Case report and review of the literature","authors":"S. Nikas, Konstantinos Tigkiropoulos, I. Lazaridis, Nikoletta Kolaki, M. Tympanidou, Kyriakos Stavridis, D. Karamanos, N. Saratzis","doi":"10.15761/vdt.1000167","DOIUrl":"https://doi.org/10.15761/vdt.1000167","url":null,"abstract":"Purpose: To present the succesfull endovascular repair of impending rupture of thoracic saccular aneurysm in patient with MAGIC syndrome. Case: A 51-year-old man with a history of MAGIC syndrome was transferred to our vascular unit with a 3 days history of thoracic pain and hemoptysis. Contrast enhanced computed tomography depicted a contained rupture of a saccular aneurysm in the distal part of descending thoracic aorta. The patient was successfully managed with thoracic endovascular aortic repair (TEVAR) and Anti-TNFa factor. His immediate postoperative course was uneventful. Follow up at 2 months depicted thrombosed saccular aneurysm with excellent patency and absence of migration and endoleak. Conclusion: Mid-term outcome of endovascular repair in patients with MAGIC syndrome seems to be safe. Due to the nature of the disease and its rarity, more studies are necessary to establish its efficacy. *Correspondence to: Tigkiropoulos K, Vascular Unit,1st Department of Surgery, Aristotle University Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece, Tel: 00306944173723; E-mail: kostastig@yahoo.com Received: July 23, 2019; Accepted: July 30, 2019; Published: August 02, 2019 Introduction MAGIC (Mouth And Genital ulcers with Inflamed Cartilage) syndrome is a very rare entity, which includes clinical manifestations of Behçet’s disease (BD) and Relapsing Polychondritis (RP) [1]. Aneurysms are considered a common complication in patients with MAGIC syndrome (21.1%), even under immunosuppression therapy, requiring emergency surgery due to its clinical presentation. Vascular involvement occurs in 14.7%-27.7% of Behcet’s Disease patients [2-4]. Aortic aneurysm is well described pathology even in this subpopulation, and its optimal treatment with immunosuppressant therapy and surgical treatment, remains to be defined. In Relapsing Polychondritis patients, aneurysms or aortitis develop in 5-10% of the patients and are multiple in 50% of them, usually involving the ascending aorta [2]. They are characterized by their presence even during remission of the disease and under lifelong immunosuppression therapy [3]. Aortic involvement is generally asymptomatic, most patients present with sudden rupture of the arterial wall with devastating and poor outcome. These aneurysms typically have a faster growing rate and rupture more easily, due to the inflammatory nature of the underlying disease. The recommended treatment for aneurysmatic disease in patients with Behçet’s Disease and Relapsing Polychondritis is based on series of isolated cases reports with small number of patients, including lifelong immunosuppressant therapy and surgical intervention, either open or endovascular. We report the successful endovascular repair of a ruptured saccular aneurysm in descending thoracic aorta followed by Anti-TNFa therapy in a patient with MAGIC syndrome.","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117169739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nadeem Sadiq, D. Kamal, M. Sultan, S. Aziz, Khurram Akhtar, Syed Asif Akbar Shah, A. Mehmood, Aziz
Pseudoaneurysm of ascending aorta is potentially fatal but well-recognized and infrequent complication after cardiac surgeries. The presentation can be varied and may develop early as in our case or may develop even after years. Our patient had VSD closure along with RV band Resection four month earlier to the development of pseudoaneurym. Transcatheter device closure was performed with 24mm atrial setal occluder without any procedural complication. To the best of our knowledge this is the largest device ever used for closure of post surgical pseudoaneurysm.
{"title":"Management of huge ascending aortic pseudo aneurysm with transcatheter device","authors":"Nadeem Sadiq, D. Kamal, M. Sultan, S. Aziz, Khurram Akhtar, Syed Asif Akbar Shah, A. Mehmood, Aziz","doi":"10.15761/vdt.1000158","DOIUrl":"https://doi.org/10.15761/vdt.1000158","url":null,"abstract":"Pseudoaneurysm of ascending aorta is potentially fatal but well-recognized and infrequent complication after cardiac surgeries. The presentation can be varied and may develop early as in our case or may develop even after years. Our patient had VSD closure along with RV band Resection four month earlier to the development of pseudoaneurym. Transcatheter device closure was performed with 24mm atrial setal occluder without any procedural complication. To the best of our knowledge this is the largest device ever used for closure of post surgical pseudoaneurysm.","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"10 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120906576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cavallini Alvise, Ferrari Ruffino Salvatore, Marcer Daniela
{"title":"Endovenous laser ablation of incompetent saphenous veins with a 1940 nm laser","authors":"Cavallini Alvise, Ferrari Ruffino Salvatore, Marcer Daniela","doi":"10.15761/vdt.1000190","DOIUrl":"https://doi.org/10.15761/vdt.1000190","url":null,"abstract":"","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131200251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Endocarditis can cause peripheral emboli leading to acute limb ischemia (ALI). The standard of care for ALI from Infective Endocarditis (IE) is not established. Case Presentation: 19-year-old male with mitral valve IE had acute bilateral limb ischemia. On the left leg, the angiograms showed occlusion of iliac and superficial femoral (SFA) arteries. These lesions were unsuccessfully treated with balloon angioplasty but overnight Ultrasound catheter directed thrombolysis or Ekos thrombolysis (Ekos corporation) given at 24 mg of tissue plasminogen activator for 12 hours resulted in patency of SFA and Iliac arteries. However, the profunda femoris artery (PFA) became occluded due to embolization after Ekos lysis. Balloon angioplasty of PFA was unsuccessful and Rheolytic thrombectomy failed as well but direct aspiration of the vegetation material with a 7F guiding catheter was successful and the PFA patency was recovered, however there was distal embolization resulted in occlusion of the distal popliteal artery. Aspiration thrombectomy was successful in causing one vessel patency to the foot. The right leg had occluded PFA and popliteal artery and balloon angioplasty failed but again an excellent response to overnight Ekos thrombolysis was seen with patency of popliteal artery. The aspiration material was sent to pathology laboratory and showed IE emboli. The patient had a good angiographic and clinical result from percutaneous ultrasound catheter directed thrombolysis. The mitral valve needed to be replaced but the lower extremities had no further clinical sequelae over 6 months of follow up. Conclusions: IE septic emboli may be treated with ultrasound enhanced catheter directed thrombolysis and also by aspiration thrombectomy. Balloon angioplasty alone led to poor outcomes in our patient.
{"title":"Ultrasound assisted catheter directed thrombolysis and aspiration thrombectomy for acute limb ischemia caused by embolization of infective endocarditis vegetations","authors":"K. Kang, R. Maholic, Gurjaipal Kang","doi":"10.15761/VDT.1000178","DOIUrl":"https://doi.org/10.15761/VDT.1000178","url":null,"abstract":"Background: Endocarditis can cause peripheral emboli leading to acute limb ischemia (ALI). The standard of care for ALI from Infective Endocarditis (IE) is not established. Case Presentation: 19-year-old male with mitral valve IE had acute bilateral limb ischemia. On the left leg, the angiograms showed occlusion of iliac and superficial femoral (SFA) arteries. These lesions were unsuccessfully treated with balloon angioplasty but overnight Ultrasound catheter directed thrombolysis or Ekos thrombolysis (Ekos corporation) given at 24 mg of tissue plasminogen activator for 12 hours resulted in patency of SFA and Iliac arteries. However, the profunda femoris artery (PFA) became occluded due to embolization after Ekos lysis. Balloon angioplasty of PFA was unsuccessful and Rheolytic thrombectomy failed as well but direct aspiration of the vegetation material with a 7F guiding catheter was successful and the PFA patency was recovered, however there was distal embolization resulted in occlusion of the distal popliteal artery. Aspiration thrombectomy was successful in causing one vessel patency to the foot. The right leg had occluded PFA and popliteal artery and balloon angioplasty failed but again an excellent response to overnight Ekos thrombolysis was seen with patency of popliteal artery. The aspiration material was sent to pathology laboratory and showed IE emboli. The patient had a good angiographic and clinical result from percutaneous ultrasound catheter directed thrombolysis. The mitral valve needed to be replaced but the lower extremities had no further clinical sequelae over 6 months of follow up. Conclusions: IE septic emboli may be treated with ultrasound enhanced catheter directed thrombolysis and also by aspiration thrombectomy. Balloon angioplasty alone led to poor outcomes in our patient.","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130602000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Dragic, Danica Momčičević, Biljana Zlojutro, Milka Jandrić, T. Kovačević, V. Djajić, A. Gajić, G. Talić, P. Kovacevic
{"title":"Serum levels of nitric oxide and endothelin-1 in vasculopathy managed with hyperbaric oxygen therapy","authors":"S. Dragic, Danica Momčičević, Biljana Zlojutro, Milka Jandrić, T. Kovačević, V. Djajić, A. Gajić, G. Talić, P. Kovacevic","doi":"10.15761/vdt.1000172","DOIUrl":"https://doi.org/10.15761/vdt.1000172","url":null,"abstract":"","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130160025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Tanislav, D. Erkapic, D. Guenduez, Marco Meyer, Marina Herceg, K. Kostev
Background: We aimed to investigate prescriptions for oral anticoagulants (OACs) in atrial fibrillation (AF) newly diagnosed patients (2009-2018). Analyzing both primary and secondary prevention, we also evaluated variables associated with OAC prescription. Methods: This study is based on data from the representative nationwide Disease Analyzer database (IQVIA). Patients with an initial AF diagnosis between 2009 and 2018 were selected and categorized as stroke or non-stroke, as well as according to their CHA 2 DS 2 -VASc score (<2 or ≥ 2). The prevalence of OAC use was calculated (2009-2018). We adopted multivariate logistic regression models to analyze differences. Results: The proportion of OAC therapy increased from 32.2% in 2009 to 56.9% in 2018 in stroke patients and from 26.6% to 48.9% in non-stroke patients with CHD 2 DS 2 -VASc scores ≥ 2. When comparing AF patients treated with OACs in 2016-2018 versus those in 2009-2011, we observed a slight increase in age, but a considerable increase in dementia. In 2016-2018 neither age nor dementia were associated with prescription of OAC in stroke patients. Furthermore, in stroke patients, OAC treatment was negatively associated with ischemic heart disease (IHD) (29.8% in treated versus 46.0% in non-treated patients, p<0.001). In non-stroke patients with CHA 2 DS 2 -VASc scores ≥ 2, OAC therapy was negatively associated with an age >80 years, peripheral artery disease, IHD, and dementia. Conclusion: A considerable increase in OAC-treated patients with CHA 2 DS 2 -VASc scores ≥ 2 was noted from 2009 to 2018. There is still a restrain considering OA in AF patients in primary prevention in elderly >80 years and those with dementia.
{"title":"A long-term analysis in the primary and secondary prevention in Atrial Fibrillation","authors":"C. Tanislav, D. Erkapic, D. Guenduez, Marco Meyer, Marina Herceg, K. Kostev","doi":"10.15761/vdt.1000170","DOIUrl":"https://doi.org/10.15761/vdt.1000170","url":null,"abstract":"Background: We aimed to investigate prescriptions for oral anticoagulants (OACs) in atrial fibrillation (AF) newly diagnosed patients (2009-2018). Analyzing both primary and secondary prevention, we also evaluated variables associated with OAC prescription. Methods: This study is based on data from the representative nationwide Disease Analyzer database (IQVIA). Patients with an initial AF diagnosis between 2009 and 2018 were selected and categorized as stroke or non-stroke, as well as according to their CHA 2 DS 2 -VASc score (<2 or ≥ 2). The prevalence of OAC use was calculated (2009-2018). We adopted multivariate logistic regression models to analyze differences. Results: The proportion of OAC therapy increased from 32.2% in 2009 to 56.9% in 2018 in stroke patients and from 26.6% to 48.9% in non-stroke patients with CHD 2 DS 2 -VASc scores ≥ 2. When comparing AF patients treated with OACs in 2016-2018 versus those in 2009-2011, we observed a slight increase in age, but a considerable increase in dementia. In 2016-2018 neither age nor dementia were associated with prescription of OAC in stroke patients. Furthermore, in stroke patients, OAC treatment was negatively associated with ischemic heart disease (IHD) (29.8% in treated versus 46.0% in non-treated patients, p<0.001). In non-stroke patients with CHA 2 DS 2 -VASc scores ≥ 2, OAC therapy was negatively associated with an age >80 years, peripheral artery disease, IHD, and dementia. Conclusion: A considerable increase in OAC-treated patients with CHA 2 DS 2 -VASc scores ≥ 2 was noted from 2009 to 2018. There is still a restrain considering OA in AF patients in primary prevention in elderly >80 years and those with dementia.","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"36 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120993745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
It is a well-documented declaration that the Native American (NA)/ American Indian (AI) population is disproportionately affected by many chronic conditions. Among the chronic and often fatal ailments, diabetes mellitus (DM) is a prevailing diagnosis [1]. According to the 2017 American Diabetes Association, DM is responsible for significant deaths and is a substantial cost to society at $327 billion USD in the United States (US) [2]. Complications of DM include peripheral artery disease (PAD), a macrovascular complication, and peripheral neuropathy (PN), a microvascular condition, which in turn cascade into other adverse health outcomes [3,4]. Impaired vascular flow and loss of sensitivity to the extremities, particularly to the feet, likewise increases risk of diabetic foot ulceration (DFU) [3,4]. As a consequence of an infected foot ulceration and subsequent osteomyelitis or gangrene, patients may undergo lower extremity amputation (LEA) [4,5]. DFU not only limits mobility and causes pain and discomfort, but foot ulceration may even increase mortality rates and reduce life expectancy [6,7]. The rate of recurrence for DFU within 1 year is roughly 40%, about 60% within 3 years, and 65% within 5 years [8].
{"title":"Disparities in lower extremity amputation among native americans with diabetic foot ulcerations","authors":"Lyndsay A. Kandi, Tze-Woei Tan","doi":"10.15761/VDT.1000176","DOIUrl":"https://doi.org/10.15761/VDT.1000176","url":null,"abstract":"It is a well-documented declaration that the Native American (NA)/ American Indian (AI) population is disproportionately affected by many chronic conditions. Among the chronic and often fatal ailments, diabetes mellitus (DM) is a prevailing diagnosis [1]. According to the 2017 American Diabetes Association, DM is responsible for significant deaths and is a substantial cost to society at $327 billion USD in the United States (US) [2]. Complications of DM include peripheral artery disease (PAD), a macrovascular complication, and peripheral neuropathy (PN), a microvascular condition, which in turn cascade into other adverse health outcomes [3,4]. Impaired vascular flow and loss of sensitivity to the extremities, particularly to the feet, likewise increases risk of diabetic foot ulceration (DFU) [3,4]. As a consequence of an infected foot ulceration and subsequent osteomyelitis or gangrene, patients may undergo lower extremity amputation (LEA) [4,5]. DFU not only limits mobility and causes pain and discomfort, but foot ulceration may even increase mortality rates and reduce life expectancy [6,7]. The rate of recurrence for DFU within 1 year is roughly 40%, about 60% within 3 years, and 65% within 5 years [8].","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"103 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117034278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Masaaki Hokari, Daisuke Shimbo, Masayuki Gekka, K. Uchida, K. Asaoka, Koji Itamoto
{"title":"Surgical outcomes of and suggestions for carotid endarterectomy in patients on hemodialysis: report of 7 cases and literature review","authors":"Masaaki Hokari, Daisuke Shimbo, Masayuki Gekka, K. Uchida, K. Asaoka, Koji Itamoto","doi":"10.15761/vdt.1000186","DOIUrl":"https://doi.org/10.15761/vdt.1000186","url":null,"abstract":"","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126571821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case report with Transesophageal Echocardiography and CMR","authors":"Nguyen Tuan Vu","doi":"10.15761/vdt.1000192","DOIUrl":"https://doi.org/10.15761/vdt.1000192","url":null,"abstract":"","PeriodicalId":206117,"journal":{"name":"Vascular Diseases and Therapeutics","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133087053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：